Retained Earnings (Accumulated Deficit) of POINT Biopharma Global Inc. from 30 Jun 2020 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
POINT Biopharma Global Inc. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 30 Jun 2020 to 30 Sep 2023.
  • POINT Biopharma Global Inc. Retained Earnings (Accumulated Deficit) for the quarter ending 30 Sep 2023 was $27,707,358, a 78% increase year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

POINT Biopharma Global Inc. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $27,707,358 +$96,551,240 +78% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $2,933,005 +$97,312,524 +97% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $22,477,834 +$98,143,116 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $39,008,505 +$98,293,213 31 Dec 2022 10-Q 13 Nov 2023 2023 Q3
Q3 2022 $124,258,598 -$79,170,660 -176% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $100,245,529 -$72,274,223 -258% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $75,665,282 -$73,954,729 -4323% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $59,284,708 -$45,902,481 -343% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 $45,087,938 -$44,903,230 -24310% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $27,971,306 -$27,951,937 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 $1,710,553 31 Mar 2021 10-Q 29 Apr 2021 2021 Q1
Q4 2020 $13,382,227 31 Dec 2020 10-K 25 Mar 2022 2021 FY
Q3 2020 $184,708 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $19,369* 30 Jun 2020 10-Q 20 Aug 2020 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.